Ming Yan, CHIEF TECHNOLOGY OFFICER at Cytek Biosciences, Inc. (CTKB), sold 20,000 shares at $5.87 ($117K) on 2024-04-19, disclosed to the SEC on 2024-04-23.
Scheduled sale ($117k) by CHIEF TECHNOLOGY OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CTKB | SELL | 2023-12-21 | $189K | — | Filing → |
| CTKB | SELL | 2023-11-21 | $121K | — | Filing → |
| CTKB | SELL | 2023-10-23 | $96K | — | Filing → |